- Home
- CRNX vs ATEC Comparison
CRNX vs ATEC Comparison
Compare CRNX & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ATEC
- Stock Information
- Founded
- CRNX 2008
- ATEC 1990
- Country
- CRNX United States
- ATEC United States
- Employees
- CRNX N/A
- ATEC N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ATEC Medical/Dental Instruments
- Sector
- CRNX Health Care
- ATEC Health Care
- Exchange
- CRNX Nasdaq
- ATEC Nasdaq
- Market Cap
- CRNX 2.8B
- ATEC 2.3B
- IPO Year
- CRNX 2018
- ATEC 2006
- Fundamental
- Price
- CRNX $41.56
- ATEC $14.90
- Analyst Decision
- CRNX Buy
- ATEC Strong Buy
- Analyst Count
- CRNX 12
- ATEC 8
- Target Price
- CRNX $74.45
- ATEC $17.13
- AVG Volume (30 Days)
- CRNX 2.1M
- ATEC 1.8M
- Earning Date
- CRNX 11-06-2025
- ATEC 10-30-2025
- Dividend Yield
- CRNX N/A
- ATEC N/A
- EPS Growth
- CRNX N/A
- ATEC N/A
- EPS
- CRNX N/A
- ATEC N/A
- Revenue
- CRNX $1,392,000.00
- ATEC $682,236,000.00
- Revenue This Year
- CRNX $428.87
- ATEC $23.76
- Revenue Next Year
- CRNX $958.11
- ATEC $18.20
- P/E Ratio
- CRNX N/A
- ATEC N/A
- Revenue Growth
- CRNX 0.51
- ATEC 26.27
- 52 Week Low
- CRNX $24.10
- ATEC $5.08
- 52 Week High
- CRNX $62.53
- ATEC $16.70
- Technical
- Relative Strength Index (RSI)
- CRNX 54.07
- ATEC 56.15
- Support Level
- CRNX $43.72
- ATEC $13.14
- Resistance Level
- CRNX $45.95
- ATEC $14.05
- Average True Range (ATR)
- CRNX 1.78
- ATEC 0.55
- MACD
- CRNX -0.37
- ATEC 0.08
- Stochastic Oscillator
- CRNX 19.30
- ATEC 94.05
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.